Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India.
Ranolazine is used to treat chronic angina.
Glenmark's current portfolio consists of 158 products authorised for distribution in the US marketplace and 57 ANDA’s pending approval with the USFDA
The company said it will continue to pursue regulatory approval for Ryaltris and work closely with the FDA to determine the appropriate next steps.
ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 565 in its research report dated May 30, 2019.
Sharekhan recommended Hold rating on Glenmark Pharmaceuticals with a target price of Rs 595 in its research report dated May 30, 2019.
The company's consolidated revenue for 2018-19 stood at Rs 9,865.46 crore, compared to Rs 9,103.07 crore in the preceding fiscal.
The approved products is a generic version of AstraZeneca Pharmaceuticals' Nexium delayed-release capsules.
Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations.
Net Sales are expected to increase by 10.8 percent Y-o-Y (down 0.8 percent Q-o-Q) to Rs. 2,490.2 crore, according to Prabhudas Lilladher.
Glenmark's current portfolio consists of 151 products authorised for distribution in the US.
"Alessandro is currently Executive Vice President, Oncology Therapeutics and Cell Therapy for Gilead Sciences. The appointment is effective April 2, 2019," Glenmark Pharma said in a regulatory filing.
The approved products is a generic version of Boehringer Ingelheim Pharmaceuticals Inc's Micardis HCT tablets.
The approval has been granted by the USFDA to Glenmark Pharmaceuticals, US, for clobetasol propionate foam, 0.05 percent, a generic version of Olux Foam, 0.05 percent, of Mylan Pharmaceuticals, the company said in a statement.
"Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (USFDA) for Sevelamer Hydrochloride tablets in the strengths of 400 mg and 800 mg," the company said in a BSE filing.
Ryaltris is indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age
Glenmark is targeting a consolidated revenue growth of 12-15 percent over the next 3-5 years, while focusing on margin expansion, the company said.
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the USFDA for Fluocinolone Acetonide Oil, 0.01 per cent (ear drops), a generic version of DermOtic Oil.
Glenmark said it is eligible for 180 days of competitive generic therapy (CGT) exclusivity upon commercialisation.
The approved product is a generic version of Mylan Pharmaceuticals Inc's Olux-E Foam, 0.05 per cent.
The approved drug is a generic version of GlaxoSmithKline's Mepron Oral Suspension of similar strength.
Atovaquone is a generic version of Mepron oral suspension, 750 mg/5 mL, of GlaxoSmithKline LLC.
The approval granted to Glenmark Pharmaceuticals Inc by by the US Food and Drug Administration (USFDA) is for Azelaic Acid Gel, 15 per cent, which is a generic version of Finacea Gel (15 per cent) of Leo Pharma, the company said in a statement.
Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Teriflunomide tablets in the strengths of 7 mg and 14 mg, the company said in a BSE filing.
"The company intends to file an Investigational New Drug (IND) application for GBR 1342 in solid tumors and initiate a clinical trial in 2019," the company said in a regulatory filing.